Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyang Huang

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2018
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple MyelomaYan Xu, Shuhui Deng, Xuehan Mao, et al.
Frontiers in Immunology|May 26, 2023
Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemiaWenjie Xiong, Zanzan Wang, Tingyu Wang, et al.
The Oncologist|March 10, 2025
Classification of NK-large granular lymphocytic leukemia by CD56 expressionYuxi Li, Rui Cui, Ying Yu, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphomaWei Liu, Wei Liu, Hesong Zou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2024
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström MacroglobulinemiaYuting Yan, Ying Yu, Wenjie Xiong, et al.
Leukemia|October 9, 2019
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myelomaGang An, Yuting Yan, Yan Xu, et al.
Signal Transduction and Targeted Therapy|March 12, 2025
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II studyYing Yu, Yuxi Li, Rui Cui, et al.
The Journal of Clinical Investigation|December 9, 2021
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphomaShuhua Yi, Yuting Yan, Meiling Jin, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Clinical Lymphoma, Myeloma & Leukemia|April 8, 2018
Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple MyelomaYan Xu, Shuhui Deng, Xuehan Mao, et al.
Frontiers in Immunology|May 26, 2023
Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemiaWenjie Xiong, Zanzan Wang, Tingyu Wang, et al.
The Oncologist|March 10, 2025
Classification of NK-large granular lymphocytic leukemia by CD56 expressionYuxi Li, Rui Cui, Ying Yu, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphomaWei Liu, Wei Liu, Hesong Zou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2024
Determination of MYD88 and CXCR4 Mutations for Clinical Detection and Their Significance in Waldenström MacroglobulinemiaYuting Yan, Ying Yu, Wenjie Xiong, et al.
Leukemia|October 9, 2019
Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myelomaGang An, Yuting Yan, Yan Xu, et al.
Signal Transduction and Targeted Therapy|March 12, 2025
Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II studyYing Yu, Yuxi Li, Rui Cui, et al.
The Journal of Clinical Investigation|December 9, 2021
Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphomaShuhua Yi, Yuting Yan, Meiling Jin, et al.
Pageof 6